(Q42522619)

1 November 2017

title

Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage (English)

1 reference

1 November 2017

M Quik

1

1 reference

1 November 2017

Y Polonskaya

series ordinal

2

1 reference

1 November 2017

J M McIntosh

series ordinal

3

1 reference

1 November 2017

J M Kulak

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

1 November 2017

1 reference

1 November 2017

volume

112

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

619-630

1 reference

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Electrophysiological actions of nicotine on substantia nigra single units

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

The short-term effect of nicotine chewing gum in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Nicotinic receptor function: new perspectives from knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Nicotinic receptors in human brain: topography and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Spatial organization of patch and matrix compartments in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

The effects of nicotine on dopamine and DOPAC output from rat striatal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Nicotine may relieve symptoms of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Human neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Striatonigrostriatal Pathways in Primates Form an Ascending Spiral from the Shell to the Dorsolateral Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Effects of smoking in patients with early-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Nicotinic receptors in the brain: correlating physiology with function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Parkinson's disease. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Dopamine-like action of nicotine: lack of tolerance and reverse tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Stimulation of nigrostriatal dopamine neurones by nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Continuous dopamine-receptor stimulation in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Levodopa motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Pathophysiology of the basal ganglia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Continuous dopamine-receptor stimulation in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

The output organization of the substantia nigra in primate as revealed by a retrograde double labeling method

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Organization of the basal ganglia: the importance of axonal collateralization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Anatomy of the dopamine system in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Functional alpha6-containing nicotinic receptors are present in chick retina

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

Presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900106-9

7 January 2021

10.1016/S0306-4522(02)00106-9

Identifiers

DOI

1 reference

1 November 2017

1 reference